BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24219508)

  • 1. Efficacy and safety of mirodenafil for patients with erectile dysfunction: a meta-analysis of three multicenter, randomized, double-blind, placebo-controlled clinical trials.
    Du W; Li J; Fan N; Shang P; Wang Z; Ding H
    Aging Male; 2014 Jun; 17(2):107-11. PubMed ID: 24219508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of oral mirodenafil in the treatment of erectile dysfunction in diabetic men in Korea: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Park HJ; Choi HK; Ahn TY; Park JK; Chung WS; Lee SW; Kim SW; Hyun JS; Park NC
    J Sex Med; 2010 Aug; 7(8):2842-50. PubMed ID: 20626604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of mirodenafil in men taking antihypertensive medications.
    Paick JS; Kim JJ; Kim SC; Moon KH; Min KS; Park K; Suh JK; Yang DY
    J Sex Med; 2010 Sep; 7(9):3143-52. PubMed ID: 20649936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction.
    Paick JS; Ahn TY; Choi HK; Chung WS; Kim JJ; Kim SC; Kim SW; Lee SW; Min KS; Moon KH; Park JK; Park K; Park NC; Suh JK; Yang DY; Jung HG
    J Sex Med; 2008 Nov; 5(11):2672-80. PubMed ID: 18638004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of udenafil in Turkish men with erectile dysfunction of psychogenic and organic aetiology: a randomized, double-blind, placebo-controlled study.
    Ortaç M; Çayan S; Çalişkan MK; Yaman MÖ; Okutucu TM; Semerci MB; Altay AB; Balbay MD; Özcan MF; Kadioğlu A
    Andrology; 2013 Jul; 1(4):549-55. PubMed ID: 23785019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of udenafil for erectile dysfunction: a meta-analysis of randomized controlled trials.
    Ding H; Du W; Wang H; Zhang L; Wang Z; Du C; Tao Y
    Urology; 2012 Jul; 80(1):134-9. PubMed ID: 22497982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Zhao C; Kim SW; Yang DY; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Min KS; Park K; Park JK
    Eur Urol; 2011 Aug; 60(2):380-7. PubMed ID: 21458153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of once daily administration of 50 mg mirodenafil in patients with erectile dysfunction: a multicenter, double-blind, placebo controlled trial.
    Chung JH; Kang DH; Oh CY; Chung JM; Lee KS; Kim TH; Moon KH; Lee W; Cho JM; Lee SW
    J Urol; 2013 Mar; 189(3):1006-13. PubMed ID: 23017527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Efficacy and safety of mirodenafil for patients with erectile dysfunction: a meta-analysis of three multicenter, randomized, double-blind, placebo-controlled clinical trials.
    Li J; Shi Q; Wei Q; Han P
    Aging Male; 2015 Jun; 18(2):71. PubMed ID: 25162329
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of avanafil for treating erectile dysfunction: results of a multicentre, randomized, double-blind, placebo-controlled trial.
    Zhao C; Kim SW; Yang DY; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Moon KH; Chung WS; Min KS; Suh JK; Hyun JS; Park K; Park JK
    BJU Int; 2012 Dec; 110(11):1801-6. PubMed ID: 22448738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
    Porst H; Gacci M; Büttner H; Henneges C; Boess F
    Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A therapeutic confirmatory study to assess the safety and efficacy of Zydena (udenafil) for the treatment of erectile dysfunction in male patients with diabetes mellitus.
    Moon du G; Yang DY; Lee CH; Ahn TY; Min KS; Park K; Park JK; Kim JJ
    J Sex Med; 2011 Jul; 8(7):2048-61. PubMed ID: 21554549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction.
    Paick JS; Kim SW; Yang DY; Kim JJ; Lee SW; Ahn TY; Choi HK; Suh JK; Kim SC
    J Sex Med; 2008 Apr; 5(4):946-953. PubMed ID: 18221288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of oral SK3530 for the treatment of erectile dysfunction in Korean men: a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel group clinical trial.
    Paick JS; Choi HK; Kim SC; Ahn TY; Kim JJ; Park JK; Park KS; Lee SW; Kim SW; Park K; Jung H; Park NC
    Asian J Androl; 2008 Sep; 10(5):791-8. PubMed ID: 18645683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of phosphodiesterase-5 inhibitors for treating erectile dysfunction in kidney transplant recipients: a meta-analysis.
    Fanbin L; Mei Y; Yan Z; Yirong Y; Shaoling Z; Yong C; Peng X
    Exp Clin Transplant; 2014 Jun; 12(3):184-9. PubMed ID: 24907716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
    Skoumal R; Chen J; Kula K; Breza J; Calomfirescu N; Basson BR; Kopernicky V
    Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).
    Montorsi F; Brock G; Stolzenburg JU; Mulhall J; Moncada I; Patel HR; Chevallier D; Krajka K; Henneges C; Dickson R; Büttner H
    Eur Urol; 2014 Mar; 65(3):587-96. PubMed ID: 24169081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of udenafil for the treatment of erectile dysfunction up to 12 hours after dosing: a randomized placebo-controlled trial.
    Park HJ; Park JK; Park K; Min K; Park NC
    J Sex Med; 2010 Jun; 7(6):2209-2216. PubMed ID: 20412426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of udenafil for the treatment of erectile dysfunction after total mesorectal excision of rectal cancer: a randomized, double-blind, placebo-controlled trial.
    Park SY; Choi GS; Park JS; Kim HJ; Park JA; Choi JI
    Surgery; 2015 Jan; 157(1):64-71. PubMed ID: 25482466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Therapeutic Confirmatory Study to Evaluate the Safety and Efficacy of Avanafil in Korean Patients with Erectile Dysfunction.
    Park HJ; Kim SW; Kim JJ; Lee SW; Paick JS; Ahn TY; Park K; Park JK; Park NC
    J Korean Med Sci; 2017 Jun; 32(6):1016-1023. PubMed ID: 28480661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.